Status:

COMPLETED

fMRI of Hypothalamic Responses to Glucose, Fructose, Sucrose and Sucralose

Lead Sponsor:

Unilever R&D

Collaborating Sponsors:

Leiden University Medical Center

Conditions:

Healthy

Eligibility:

MALE

18-25 years

Phase:

NA

Brief Summary

The study will consist of five occasions with one week in between. BOLD signal intensity of the hypothalamus will be measured using fMRI. Measurements will be done before and after drinking 300 ml pla...

Detailed Description

The hypothalamus is known to be important for control of feeding behaviour as well as the regulation of temperature. Functional magnetic resonance imaging (fMRI) is a non-invasive method, which detect...

Eligibility Criteria

Inclusion

  • Signed informed consent
  • Age between 18 and 25 years
  • BMI between 20 and 24 kg/m2
  • Length between 170 and 190 centimetres

Exclusion

  • Diabetes or history of other disturbances of glucose metabolism (eg impaired glucose tolerance, hypoglycaemia).
  • Any genetic or psychiatric disease (e.g. fragile X syndrome, major depression) affecting brain
  • Any significant chronic disease
  • Renal or hepatic disease
  • Recent weight changes or attempts to lose weight (\> 3 kg weight gain or loss, within the last 3 months)
  • Smoking (current or last 6 months)
  • Alcohol consumption of more than 21 units per week or use of recreational drugs at present or in the last year
  • Recent blood donation (within the last 2 months)
  • Recent participation in other biomedical research projects (within the last 3 months), participation in 3 or more biomedical research projects in one year
  • Contra-indication to MRI scanning:
  • Claustrophobia
  • Pacemakers and defibrillators
  • Nerve stimulators
  • Intracranial clips
  • Intraorbital or intraocular metallic fragments
  • Cochlear implants
  • Ferromagnetic implants

Key Trial Info

Start Date :

February 22 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 22 2015

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT03247114

Start Date

February 22 2015

End Date

May 22 2015

Last Update

August 11 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Leids Universitair Medisch Centrum

Leiden, South Holland, Netherlands

fMRI of Hypothalamic Responses to Glucose, Fructose, Sucrose and Sucralose | DecenTrialz